Literature DB >> 2475821

Serotonin metabolism in migraine.

M D Ferrari1, J Odink, C Tapparelli, G M Van Kempen, E J Pennings, G W Bruyn.   

Abstract

To investigate systemic serotonin (5-HT) metabolism in migraine, we determined platelet and platelet-free plasma concentrations of 5-HT, its precursors tryptophan and 5-hydroxytryptophan, and its main metabolite 5-hydroxyindoleacetic acid (5-HIAA), as well as the activities of the platelet enzymes monoamine oxidase and phenolsulfotransferase in classic and common migraineurs. Between attacks, migraineurs had lower plasma 5-HT and higher 5-HIAA levels than did healthy controls and patients with tension headache. During migraine attacks, plasma 5-HT levels were substantially higher than during attack-free periods, while 5-HIAA concentrations and platelet enzyme activities were lower. Platelet 5-HT was reduced only during common, but not classic, migraine attacks. We hypothesize that systemic 5-HT metabolism is enhanced in migraineurs during headache-free periods and transiently decreases during attacks, presumably due to a fall in enzymatic degradation. Furthermore, platelet behavior differs during migraine attacks with and without aura, and release of platelet 5-HT cannot (exclusively) be held accountable for the rise of plasma 5-HT during migraine attacks.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475821     DOI: 10.1212/wnl.39.9.1239

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Episodic and chronic migraineurs are hypersensitive to thermal stimuli between migraine attacks.

Authors:  Todd J Schwedt; Melissa J Krauss; Karen Frey; Robert W Gereau
Journal:  Cephalalgia       Date:  2010-04-07       Impact factor: 6.292

Review 3.  5-HT3 receptor antagonists and migraine therapy.

Authors:  M D Ferrari
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

4.  A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach.

Authors:  Matthew P Johnson; Lyn R Griffiths
Journal:  J Hum Genet       Date:  2005-10-01       Impact factor: 3.172

Review 5.  Where does a migraine attack originate? In the brainstem.

Authors:  J Tajti; D Szok; Á Párdutz; B Tuka; A Csáti; A Kuris; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

Review 6.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

Review 7.  Serotonin and migraine: a reconsideration of the central theory.

Authors:  Alessandro Panconesi
Journal:  J Headache Pain       Date:  2008-07-31       Impact factor: 7.277

8.  Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura.

Authors:  G D'Andrea; L Hasselmark; M Alecci; A Cananzi; F Perini; K M Welch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

9.  Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.

Authors:  Geoffrey Andrew Lambert; Cathy Donaldson; Karen Lisa Hoskin; Peter Michael Boers; Alessandro Stefano Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000

Review 10.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.